the effects of 10 weeks of treatment with isradipine ( isrp ) , a new dihydropyridine ca antagonist , was evaluated in a prospective , randomized , double-blind , parallel group , hydrochlorothiazide ( hctz ) controlled study in patients with mild to moderate hypertension .
C0020261
hydrochlorothiazide
C0020538
hypertension